Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Ding Ding, Amy Hacker-Prietz, Jin He, Lei Zheng, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2021;39(4):304-314. Published online 2021 Dec 17 DOI: https://doi.org/10.3857/roj.2021.00815
Citations to this article as recorded by 
The Current Role of Radiation in Pancreatic Cancer and Future Directions
Colin S. Hill, Joseph M. Herman
Clinical Colorectal Cancer.2023; 22(1): 12. CrossRef
Multifunctional 99mTc-5-azacitidine Gold Nanoparticles: Formulation,
In Vitro Cytotoxicity, Radiosynthesis, and In Vivo Pharmacokinetic Study
Samar S. Ezz Eldin, Hassan M. Rashed, Amira H. Hassan, Heba F. Salem, Tamer M. Sakr
Current Drug Delivery.2023; 20(4): 387. CrossRef
One-Week versus Two-Week Chemoradiotherapy Followed by Curative Surgery in Rectal Cancer: Long-Term Comparative Pooled Analysis of Two Prospective Multicenter Phase II Trials
Soo-Yoon Sung, Dae Yong Kim, Hong Seok Jang, Tae Hyun Kim, Hee Chul Park, Eui Kyu Chie, Taek-Keun Nam, Sung Hwan Kim, Jong Hoon Lee
Cancer Research and Treatment.2023; 55(3): 918. CrossRef
How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
Daria Kwaśniewska, Marta Fudalej, Paweł Nurzyński, Anna Badowska-Kozakiewicz, Aleksandra Czerw, Elżbieta Cipora, Katarzyna Sygit, Ewa Bandurska, Andrzej Deptała
Cancers.2023; 15(17): 4275. CrossRef
Neoadjuvant treatment of pancreatic adenocarcinoma: Chemoradiation or stereotactic body radiation therapy?
F. Huguet, C. Cerbai, M.H. Ta, T. Sarrade, C. Evin, S. Aziez, E. Rivin del Campo, B. Durand, M. Loi
Cancer/Radiothérapie.2022; 26(6-7): 858. CrossRef
Borderline Resectable Pancreatic Cancer: Challenges for Clinical Management
Ali Fawaz, Omar Abdel-Rahman
Cancer Management and Research.2022; Volume 14: 3589. CrossRef